Stay updated with breaking news from Pardes Biosciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
This randomized study examines the effect of higher-dose fluvoxamine on time to sustained recovery from mild to moderate COVID-19 or progression to severe disea
In this Viewpoint, the authors summarize the therapeutic landscape for COVID-19, discuss who is most likely to benefit from treatment, provide an update on mana
PRDS | Complete Pardes Biosciences Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
As previously announced, on July 16, 2023, MediPacific Sub, Inc. and MediPacific, Inc. , affiliates of Foresite Capital, entered into a definitive agreement and plan of merger with Pardes...
As previously announced, on July 16, 2023, MediPacific Sub, Inc. and MediPacific, Inc. , affiliates of Foresite Capital, entered into a definitive agreement and plan of merger with Pardes...